ATE236921T1 - L-ribavirin und dessen verwendung - Google Patents

L-ribavirin und dessen verwendung

Info

Publication number
ATE236921T1
ATE236921T1 AT01108303T AT01108303T ATE236921T1 AT E236921 T1 ATE236921 T1 AT E236921T1 AT 01108303 T AT01108303 T AT 01108303T AT 01108303 T AT01108303 T AT 01108303T AT E236921 T1 ATE236921 T1 AT E236921T1
Authority
AT
Austria
Prior art keywords
compounds
useful
novel
diseases
infestations
Prior art date
Application number
AT01108303T
Other languages
English (en)
Inventor
Kandasamy Ramasamy
Robert Tam
Devron Averett
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Application granted granted Critical
Publication of ATE236921T1 publication Critical patent/ATE236921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
AT01108303T 1996-10-16 1997-10-15 L-ribavirin und dessen verwendung ATE236921T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2858596P 1996-10-16 1996-10-16

Publications (1)

Publication Number Publication Date
ATE236921T1 true ATE236921T1 (de) 2003-04-15

Family

ID=21844262

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01108303T ATE236921T1 (de) 1996-10-16 1997-10-15 L-ribavirin und dessen verwendung
AT97912762T ATE238328T1 (de) 1996-10-16 1997-10-15 Monozyklische l-nukleoside, analoga und ihre anwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97912762T ATE238328T1 (de) 1996-10-16 1997-10-15 Monozyklische l-nukleoside, analoga und ihre anwendungen

Country Status (25)

Country Link
US (4) US6130326A (de)
EP (1) EP1027359B9 (de)
JP (2) JP2002503212A (de)
KR (1) KR100398923B1 (de)
CN (1) CN1268140A (de)
AT (2) ATE236921T1 (de)
AU (1) AU738170B2 (de)
BR (1) BR9712527A (de)
CA (1) CA2267279A1 (de)
CZ (1) CZ120699A3 (de)
DE (2) DE69720811T2 (de)
DK (2) DK1027359T3 (de)
ES (2) ES2195125T3 (de)
HU (1) HUP0001107A3 (de)
IL (1) IL129126A0 (de)
NO (1) NO313417B1 (de)
NZ (1) NZ334915A (de)
PL (1) PL187107B1 (de)
PT (2) PT1027359E (de)
RU (2) RU2188828C2 (de)
SI (1) SI20076A (de)
SK (1) SK284054B6 (de)
UA (1) UA63915C2 (de)
WO (1) WO1998016186A2 (de)
YU (1) YU18799A (de)

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1027359B9 (de) * 1996-10-16 2003-09-17 Ribapharm, Inc. Monozyklische l-nukleoside, analoga und ihre anwendungen
US6033399A (en) 1997-04-09 2000-03-07 Valleylab, Inc. Electrosurgical generator with adaptive power control
CN1261370A (zh) * 1997-06-30 2000-07-26 Icn药品公司 生产噻唑呋林及其它c－核苷的方法
JP4596495B2 (ja) * 1997-07-18 2010-12-08 ソニー株式会社 制御装置、制御方法、電気機器システム、電気機器システムの制御方法、および、記録媒体
US7364577B2 (en) 2002-02-11 2008-04-29 Sherwood Services Ag Vessel sealing system
US20040167508A1 (en) 2002-02-11 2004-08-26 Robert Wham Vessel sealing system
US7901400B2 (en) 1998-10-23 2011-03-08 Covidien Ag Method and system for controlling output of RF medical generator
US7137980B2 (en) 1998-10-23 2006-11-21 Sherwood Services Ag Method and system for controlling output of RF medical generator
ES2262366T3 (es) * 1998-11-05 2006-11-16 Centre National De La Recherche Scientifique Derivados azido de beta-l-2'-desoxi-nucleosidos para el tratamiento de la infeccin por vih.
IL142983A0 (en) 1998-11-05 2002-04-21 Centre Nat Rech Scient Nucleosides with anti-hepatisis b virus activity
US6407077B1 (en) 1998-11-05 2002-06-18 Emory University β-L nucleosides for the treatment of HIV infection
CN1334736A (zh) * 1999-01-29 2002-02-06 Icn药品公司 病毒唑对免疫反应的调节作用
US7084125B2 (en) 1999-03-18 2006-08-01 Exiqon A/S Xylo-LNA analogues
ATE356824T1 (de) 1999-05-04 2007-04-15 Santaris Pharma As L-ribo-lna analoge
US6525191B1 (en) * 1999-05-11 2003-02-25 Kanda S. Ramasamy Conformationally constrained L-nucleosides
AU7019200A (en) * 1999-08-31 2001-03-26 Nycomed Amersham Plc Nucleoside analogues
US6664399B1 (en) * 1999-09-02 2003-12-16 E. I. Du Pont De Nemours & Company Triazole linked carbohydrates
US6518253B1 (en) * 1999-11-19 2003-02-11 Robert Tam Treatment of viral infections using the L-isomer of ribavirin
CA2384326A1 (en) * 1999-12-23 2001-06-28 Johnson Lau Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
US6495677B1 (en) 2000-02-15 2002-12-17 Kanda S. Ramasamy Nucleoside compounds
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
US6455508B1 (en) * 2000-02-15 2002-09-24 Kanda S. Ramasamy Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
KR20100003313A (ko) * 2000-04-13 2010-01-07 파마셋 인코포레이티드 간염 바이러스 감염 치료를 위한 3'- 또는 2'-하이드록시메틸 치환된 뉴클레오시드 유도체
PY0111577A (es) * 2000-05-23 2017-01-02 Idenix Cayman Ltd Métodos y composiciones para el tratamiento del virus de la hepatitis c
BR0111196A (pt) * 2000-05-26 2004-04-06 Idenix Cayman Ltd Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
US6815542B2 (en) * 2000-06-16 2004-11-09 Ribapharm, Inc. Nucleoside compounds and uses thereof
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
DE60130998T2 (de) 2000-08-17 2008-07-17 Tripep Ab Ribavirin-enthaltende vakzine
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
EP1281715B1 (de) * 2001-07-30 2003-10-22 Clariant Life Science Molecules (Italia) SpA Verfahren zur Herstellung von Ribavirin
JP2005504087A (ja) * 2001-09-28 2005-02-10 イデニクス（ケイマン）リミテツド ４’が修飾されたヌクレオシドを使用するｃ型肝炎ウイルス治療のための方法および組成物
HUP0402364A2 (hu) * 2001-11-02 2005-02-28 Sandoz Ag Gyorsan oldódó, nagy koncentrációjú ribavirinkészítmények
KR100411398B1 (ko) * 2001-12-06 2003-12-18 주식회사유한양행 베타-디-리보푸라노즈 유도체의 제조방법
WO2003073989A2 (en) * 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
WO2003092520A1 (en) 2002-05-06 2003-11-13 Sherwood Services Ag Blood detector for controlling anesu and method therefor
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
CN101172993A (zh) * 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
US7608600B2 (en) * 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
AP2005003213A0 (en) * 2002-06-28 2005-03-31 Univ Cagliari 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
CA2494340C (en) * 2002-08-01 2012-01-24 Pharmasset Inc. Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
JP2005539032A (ja) * 2002-08-12 2005-12-22 エフ．ホフマン−ラ　ロシュ　アーゲー リボフラノースの製造方法
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
KR20050089799A (ko) 2002-10-29 2005-09-08 콜리 파마슈티칼 그룹, 리미티드 Ｃ형 간염 바이러스 감염의 치료에 있어 ＣｐＧ올리고뉴클레오티드의 용도
RU2005118421A (ru) * 2002-11-15 2006-01-20 Айденикс (Кайман) Лимитед (Ky) 2'-разветвленные нуклеозиды и мутация flaviviridae
TWI294882B (en) * 2002-12-09 2008-03-21 Hoffmann La Roche Anhydrous crystalline azido cytosine hemisulfate derivative
US7044948B2 (en) 2002-12-10 2006-05-16 Sherwood Services Ag Circuit for controlling arc energy from an electrosurgical generator
US7255694B2 (en) 2002-12-10 2007-08-14 Sherwood Services Ag Variable output crest factor electrosurgical generator
AU2003300901A1 (en) * 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
CN100335492C (zh) * 2002-12-23 2007-09-05 埃迪尼克斯(开曼)有限公司 生产3’－核苷前体药物的方法
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
JP2006524227A (ja) * 2003-03-28 2006-10-26 ファーマセット，インク． フラビウイルス科ウイルス感染の治療のための化合物
WO2004098385A2 (en) 2003-05-01 2004-11-18 Sherwood Services Ag Method and system for programing and controlling an electrosurgical generator system
WO2005003147A2 (en) 2003-05-30 2005-01-13 Pharmasset, Inc. Modified fluorinated nucleoside analogues
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
US20050009848A1 (en) * 2003-07-10 2005-01-13 Icn Pharmaceuticals Switzerland Ltd. Use of antivirals against inflammatory bowel diseases
AU2004258750A1 (en) * 2003-07-25 2005-02-03 Centre National De La Recherche Scientifique -Cnrs Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis C
WO2005018330A1 (en) * 2003-08-18 2005-03-03 Pharmasset, Inc. Dosing regimen for flaviviridae therapy
RU2264409C2 (ru) * 2003-10-01 2005-11-20 Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") 2`-амино-2`-дезоксинуклеозиды - ингибиторы репродукции вирусов кори и марбург
ES2372045T3 (es) 2003-10-23 2012-01-13 Covidien Ag Monitorización de temperatura redundante en sistemas electroquirúrgicos para atenuar la seguridad.
EP1676108B1 (de) 2003-10-23 2017-05-24 Covidien AG Schaltung für thermoelement-messsignalen
US7396336B2 (en) 2003-10-30 2008-07-08 Sherwood Services Ag Switched resonant ultrasonic power amplifier system
US7131860B2 (en) 2003-11-20 2006-11-07 Sherwood Services Ag Connector systems for electrosurgical generator
US7300435B2 (en) 2003-11-21 2007-11-27 Sherwood Services Ag Automatic control system for an electrosurgical generator
US7766905B2 (en) 2004-02-12 2010-08-03 Covidien Ag Method and system for continuity testing of medical electrodes
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
US7780662B2 (en) 2004-03-02 2010-08-24 Covidien Ag Vessel sealing system using capacitive RF dielectric heating
JP2008503562A (ja) * 2004-06-23 2008-02-07 イデニクス（ケイマン）リミテツド フラビウイルス科による感染症を治療するための５−アザ−７−デアザプリン誘導体
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
MX2007003085A (es) 2004-09-14 2007-08-02 Pharmasset Inc Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.
US7628786B2 (en) 2004-10-13 2009-12-08 Covidien Ag Universal foot switch contact port
US7687473B2 (en) * 2005-01-07 2010-03-30 Health Research, Inc. 5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
CA2610854A1 (en) * 2005-03-30 2006-10-05 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
CA2618429A1 (en) * 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
US8734438B2 (en) 2005-10-21 2014-05-27 Covidien Ag Circuit and method for reducing stored energy in an electrosurgical generator
US7947039B2 (en) 2005-12-12 2011-05-24 Covidien Ag Laparoscopic apparatus for performing electrosurgical procedures
US7781576B2 (en) * 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US7513896B2 (en) 2006-01-24 2009-04-07 Covidien Ag Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling
US7651493B2 (en) 2006-03-03 2010-01-26 Covidien Ag System and method for controlling electrosurgical snares
MX2008011360A (es) * 2006-03-09 2009-03-03 Om Pharma Compuestos inmunodulares y tratamiento de enfermedades relacionadas con la sobreproduccion de citoquinas inflamatorias.
FR2907786B1 (fr) * 2006-10-27 2009-09-18 Univ Grenoble 1 Thionucleosides et applications pharmaceutiques
WO2008067002A2 (en) * 2006-09-11 2008-06-05 Southern Research Institute Azole nucleosides and use as inhibitors of rna and dna varial polymerases
JP5550234B2 (ja) * 2006-12-08 2014-07-16 株式会社エーピーアイ コーポレーション フラノース誘導体の製造方法
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8071561B2 (en) * 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
ES2824261T3 (es) 2007-09-14 2021-05-11 Biogen Ma Inc Composiciones y procedimientos para el tratamiento de la leucoencefalopatía multifocal progresiva (LMP)
US8227431B2 (en) 2008-03-17 2012-07-24 Hetero Drugs Limited Nucleoside derivatives
WO2009130588A2 (en) * 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
PL2695609T3 (pl) 2008-05-15 2020-05-18 Celgene Corporation Doustne formulacje analogów cytydyny i sposoby ich zastosowania
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
WO2010075517A2 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside analogs
WO2010075554A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Synthesis of purine nucleosides
JP2012521359A (ja) * 2009-03-20 2012-09-13 アリオス バイオファーマ インク． 置換されたヌクレオシドアナログおよびヌクレオチドアナログ
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
RS54368B1 (sr) 2010-03-31 2016-04-28 Gilead Pharmasset Llc Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino)propanoat
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
JP6012605B2 (ja) 2010-09-22 2016-10-25 アリオス バイオファーマ インク． 置換されたヌクレオチドアナログ
AU2011305652B2 (en) 2010-09-22 2016-10-20 Janssen Biopharma, Inc. Azido nucleosides and nucleotide analogs
EP3042910B1 (de) 2010-11-30 2019-01-09 Gilead Pharmasset LLC 2'-spiro-nukleoside zur therapie von hepatitis c
GB201021867D0 (en) * 2010-12-23 2011-02-02 Mologen Ag Non-coding immunomodulatory DNA construct
CN102153548B (zh) * 2011-02-24 2012-11-28 河北大学 一种含有噻唑（嗪）烷酮环的类核苷衍生物及其制备方法和其在药物制剂中的应用
AU2012236476A1 (en) * 2011-03-31 2013-05-02 Celgene International Sarl Systhesis of 5-azacytidine
CN103945902B (zh) 2011-08-30 2018-07-20 阿斯泰克斯制药公司 地西他滨衍生物制剂
MD4589C1 (ro) 2011-09-16 2019-03-31 Gilead Pharmasset Llc Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
EP2794627B1 (de) 2011-12-22 2018-09-26 Alios Biopharma, Inc. Substituierte nukleoside, nukleotide und analoga davon
WO2013096680A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
EP2828277A1 (de) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Feste formen eines thiophosphoramidat-nucleotid-prodrugs
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
TW201408688A (zh) 2012-05-25 2014-03-01 Janssen R & D Ireland 尿嘧啶基螺氧環丁烷（ｓｐｉｒｏｏｘｅｔａｎｅ）核苷類
PT2935303T (pt) 2012-12-21 2021-04-30 Alios Biopharma Inc 4'-fluoro-nucleósidos, 4'-fluoro-nucleótidos e seus análogos para o tratamento de hcv
MX351816B (es) 2013-01-31 2017-10-30 Gilead Pharmasset Llc Formulacion de combinacion de dos compuestos antivirales.
KR20160003700A (ko) 2013-04-12 2016-01-11 아칠리온 파르마세우티칼스 인코포레이티드 C형간염 바이러스의 치료를 위한 고활성 뉴클레오시드 유도체
PT3038601T (pt) 2013-08-27 2020-06-30 Gilead Pharmasset Llc Formulação combinada de dois compostos antivirais
WO2015054465A1 (en) 2013-10-11 2015-04-16 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
AU2015205342B2 (en) 2014-01-07 2020-01-23 Babita Agrawal Immunomodulatory compositions and methods of use thereof
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
AU2015270090A1 (en) 2014-06-06 2016-12-22 Glaxosmithkline Intellectual Property (No.2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
WO2016003812A1 (en) 2014-07-02 2016-01-07 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
US10273305B2 (en) 2015-04-02 2019-04-30 Ablynx N.V. Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
EP3316685A4 (de) 2015-07-02 2019-03-13 Otsuka Pharmaceutical Co., Ltd. Lyophilisierte pharmazeutische zusammensetzungen
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
WO2017218580A1 (en) 2016-06-14 2017-12-21 Rejuvenation Therapeutics Corporation Synthetic methods for the preparation of nicotinamide riboside and related compounds
US10202412B2 (en) 2016-07-08 2019-02-12 Atea Pharmaceuticals, Inc. β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
RU2624018C2 (ru) * 2016-09-26 2017-06-30 Федеральное государственное бюджетное учреждение науки Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН (ИБХ РАН) Амид 5-(тетрагидрофуран-2-ил)-1,2,4-триазол-3-карбоновой кислоты, обладающий противовирусной активностью, и способ его получения
CN111182908A (zh) 2017-08-03 2020-05-19 大塚制药株式会社 药物化合物及其纯化方法
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
CA3128455A1 (en) * 2019-02-01 2020-08-06 Janssen Biopharma, Inc. Antiviral nucleosides and derivatives thereof
EP4069691B1 (de) 2019-12-06 2024-09-18 Vertex Pharmaceuticals Incorporated Substituierte tetrahydrofurane als modulatoren von natriumkanälen
PT4347031T (pt) 2021-06-04 2026-01-19 Vertex Pharma Carboxamidas de n-(hidroxialquil(hetero)aril)tetrahidrofurano como moduladores dos canais de sódio
WO2023288047A2 (en) * 2021-07-15 2023-01-19 Alnylam Pharmaceuticals, Inc. Multiplexing targeting ligands through click chemistry at the anomeric site of sugars

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3948885A (en) * 1973-03-19 1976-04-06 Icn Pharmaceuticals, Inc. 5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside
US4138547A (en) * 1977-12-22 1979-02-06 Icn Pharmaceuticals, Inc. Process for preparing 1,2,4-triazole nucleosides
DK553781A (da) * 1980-12-15 1982-06-16 Vira Tek Inc Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosulthiazol-4-carboxid-estere
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
US5041426A (en) * 1987-12-21 1991-08-20 Brigham Young University Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides
CA1317588C (en) * 1988-02-29 1993-05-11 Tohru Ueda Imidazole derivatives, process for production thereof, and use thereof
US5082829A (en) * 1989-01-24 1992-01-21 Gensia Pharmaceuticals AICA riboside prodrugs
US4992426A (en) * 1989-02-27 1991-02-12 Nucleic Acid Research Institute Antiparasitic 5'-sulfamoyl nucleosides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5248776A (en) * 1990-12-05 1993-09-28 University Of Georgia Research Foundation, Inc. Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
US5438131A (en) * 1992-09-16 1995-08-01 Bergstrom; Donald E. 3-nitropyrrole nucleoside
WO1994021658A1 (en) * 1993-03-15 1994-09-29 Kalman Thomas I Antiviral imidazolinone nucleoside derivatives
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5567689A (en) * 1993-08-13 1996-10-22 The Uab Research Foundation Methods for increasing uridine levels with L-nucleosides
US5599796A (en) * 1993-12-02 1997-02-04 Emory University Treatment of urogenital cancer with boron neutron capture therapy
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
DE19518216A1 (de) * 1994-10-07 1996-04-11 Max Delbrueck Centrum Neue ß-L-Nucleoside und ihre Verwendung
US5672594A (en) * 1994-10-24 1997-09-30 Genencor International, Inc. L-erythrosyl nucleosides
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
IT1281498B1 (it) * 1995-06-07 1998-02-18 Sardinian Antiviral Research C Pirazolo - derivati ad attivita' antitumorale, processo per la loro preparazione e composizioni farmaceutiche che li contengono , e
EP1027359B9 (de) * 1996-10-16 2003-09-17 Ribapharm, Inc. Monozyklische l-nukleoside, analoga und ihre anwendungen

Also Published As

Publication number Publication date
KR100398923B1 (ko) 2003-09-19
US6642206B2 (en) 2003-11-04
DK1027359T3 (da) 2003-08-11
HK1038365A1 (en) 2002-03-15
NO313417B1 (no) 2002-09-30
NZ334915A (en) 2000-11-24
RU2188828C2 (ru) 2002-09-10
JP2002503212A (ja) 2002-01-29
DK1132393T3 (da) 2003-07-21
PL187107B1 (pl) 2004-05-31
WO1998016186A2 (en) 1998-04-23
DE69721339D1 (de) 2003-05-28
KR20000049224A (ko) 2000-07-25
PT1027359E (pt) 2003-09-30
ATE238328T1 (de) 2003-05-15
IL129126A0 (en) 2000-02-17
UA63915C2 (uk) 2004-02-16
CN1268140A (zh) 2000-09-27
SK284054B6 (sk) 2004-08-03
AU738170B2 (en) 2001-09-13
JP2003176296A (ja) 2003-06-24
NO991785D0 (no) 1999-04-15
PL333419A1 (en) 1999-12-06
CZ120699A3 (cs) 1999-09-15
EP1027359B1 (de) 2003-04-23
WO1998016186A3 (en) 1998-06-11
SI20076A (sl) 2000-04-30
US20020095033A1 (en) 2002-07-18
DE69720811D1 (de) 2003-05-15
RU2001132536A (ru) 2003-08-20
EP1027359B9 (de) 2003-09-17
US6552183B1 (en) 2003-04-22
PT1132393E (pt) 2003-08-29
YU18799A (sh) 2002-06-19
HUP0001107A3 (en) 2003-01-28
DE69720811T2 (de) 2004-03-11
US6130326A (en) 2000-10-10
EP1027359A2 (de) 2000-08-16
ES2195970T3 (es) 2003-12-16
NO991785L (no) 1999-06-15
US6573248B2 (en) 2003-06-03
US20030018186A1 (en) 2003-01-23
SK47199A3 (en) 2000-12-11
CA2267279A1 (en) 1998-04-23
EP1027359A4 (de) 2001-07-25
DE69721339T2 (de) 2004-01-22
ES2195125T3 (es) 2003-12-01
AU4986797A (en) 1998-05-11
HUP0001107A2 (hu) 2001-06-28
HK1028977A1 (en) 2001-03-16
BR9712527A (pt) 2000-03-08

Similar Documents

Publication Publication Date Title
DE69720811D1 (de) L-Ribavirin und dessen Verwendung
DE59709414D1 (de) Oxyiminopregnancarbolactone
FI954390A7 (fi) Uusi aine solun aktiviteetin säätämiseksi
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
DE3779250D1 (de) Acrylcopolymere, diese enthaltende hautschutzmittel und ihre anwendung.
ES2069346T3 (es) Derivados de piperidina y procedimiento para su preparacion y su uso.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ES2154290T3 (es) Estimulacion de la diferenciacion celular por sindecano.
EE03170B1 (et) Perifeerse vere mononukleaarsete rakkude tsütotoksilise aktiivsuse stimuleerimine IL-10 abil
ATE93846T1 (de) S-substituierte beta-thioacrylamide und deren verwendung als mikrobizide.
DE3676838D1 (de) Dehydrierungskatalysator und dessen verwendung.
ATE247649T1 (de) Disubstituierte biphenyloxazoline
ATE155644T1 (de) Mikrobizide mittel
PT86104A (de) Pyrazoline ihre herstellung und ihre verwendung als mittel mit insektizider und akarizider wirkung
ATE215935T1 (de) Heterozyklische verbidungen mit mmp und tnf inhibitorisher wirkung
ES2086449T3 (es) 2-terbutil-4-cloro-5-(4-ibutilmetilciclohexil)-metiltio-3(h)-piridazinona con actividad acaricida e insecticida.
ATE102478T1 (de) Kosmetische und hautbehandlungszusammensetzungen.
ATE76286T1 (de) Acrylcopolymere, diese enthaltende hautschutzmittel und ihre anwendung.
DE69315672D1 (de) Verwendung von Silikonzusammensetzungen zur Behandlung von Flachdichtungen, insbesondere von Zylinderkopfdichtungen
IT218809Z2 (it) . pannello ortopedico anatomico per riposare, dormire e curare
SU1351053A1 (ru) Бензил (4-фторфенил)селенид, обладающий антимикробной и анальгетической активностью
BR6801156U (pt) Mesa de praia,lago,lagoa,rio
MX9307735A (es) Nuevas triazolopirimidonas, su obtencion y uso.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1132393

Country of ref document: EP

REN Ceased due to non-payment of the annual fee